Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
Katherine D. Ellingson

, James Hollister, Cynthia J. Porter, Sana M. Khan, Leora R. Feldstein, Allison L. Naleway, Manjusha Gaglani, Alberto J. Caban-Martinez, Harmony L. Tyner, Ashley A. Lowe, Lauren E.W. Olsho, Jennifer Meece, Sarang K. Yoon, Josephine Mak, Jennifer L. Kuntz, Natasha Schaefer Solle, Karley Respet, Zoe Baccam, Meredith G. Wesley, Matthew S. Thiese, Young M. Yoo, Marilyn J. Odean, Flavia N. Miiro, Steve L. Pickett, Andrew L. Phillips, Lauren Grant, James K. Romine, Meghan K. Herring, Kurt T. Hegmann, Julie Mayo Lamberte, Brian Sokol, Krystal S. Jovel, Mark G. Thompson, Patrick Rivers, Tamara Pilishvili, Karen Lutrick, Jefferey L. Burgess, Claire M. Midgley, and Ashley L. Fowlkes
Author affiliations: University of Arizona, Tucson, Arizona, USA (K.D. Ellingson, J. Hollister, C.J. Porter, S.M. Khan, A.A. Lowe, Z. Baccam, F.N. Miiro, J.K. Romine, K.S. Jovel, P. Rivers, K. Lutrick, J.L. Burgess); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (L.R. Feldstein, J. Mak, Y.M. Yoo, J. Mayo Lamberte, M.G. Thompson, T. Pilishvili, C.M. Midgley, A.L. Fowlkes); Kaiser Permanente Northwest, Portland, Oregon, USA (A.L. Naleway, J.L. Kuntz); B; aylor Scott and White Health, Temple, Texas, USA (M. Gaglani); A.J. Caban-Martinez, N. Schaefer Solle); St. Luke’s Regional Health Care System, Duluth, Minnesota, USA (H.L. Tyner, K. Respet, M.J. Odean); Abt Associates Inc., Rockville, Maryland, USA (L.E.W. Olsho, M.G. Wesley, S.L. Pickett, M.K. Herring, B. Sokol); Marshfield Clinic, Marshfield, Wisconsin, USA (J. Meece); University of Utah Health, Salt Lake City, Utah, USA (S.K. Yoon, M.S. Thiese, A.L. Phillips, K.T. Hegmann)
Main Article
Figure

Figure. Sample inclusion criteria and site-specific study timeline for risk factor analyses for reinfection with SARS-CoV-2 Omicron variant among previously infected frontline workers, United States.
Main Article
Page created: December 28, 2022
Page updated: February 20, 2023
Page reviewed: February 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.